Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
4.080
+0.330 (8.80%)
At close: Mar 9, 2026, 4:00 PM EDT
4.070
-0.010 (-0.25%)
After-hours: Mar 9, 2026, 7:07 PM EDT
Whitehawk Therapeutics Market Cap
Whitehawk Therapeutics has a market cap or net worth of $192.28 million as of March 9, 2026. Its market cap has increased by 172.78% in one year.
Market Cap
192.28M
Enterprise Value
29.69M
1-Year Change
172.78%
Ranking
Category
Stock Price
$4.08
Market Cap Chart
Since August 27, 2021, Whitehawk Therapeutics's market cap has decreased from $540.80M to $192.28M, a decrease of -64.44%. That is a compound annual growth rate of -20.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 176.73M | 54.96% |
| Dec 31, 2025 | 114.05M | 46.67% |
| Dec 31, 2024 | 77.76M | 56.96% |
| Dec 29, 2023 | 49.54M | -84.17% |
| Dec 30, 2022 | 312.99M | -37.97% |
| Dec 31, 2021 | 504.59M | -6.70% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Molecular Partners AG | 187.40M |
| Kalaris Therapeutics | 183.66M |
| Heron Therapeutics | 182.24M |
| SAB Biotherapeutics | 180.43M |
| Cartesian Therapeutics | 178.12M |
| Nkarta | 177.57M |
| Tiziana Life Sciences | 177.40M |
| Vaxart | 177.33M |